Stocks wobble with inflation data in focus
Companies in the S&P 500 (^GSPC) have reported what’s broadly been considered a solid Q1 earnings season for the index, with one key exception: drugmaker Bristol Myers Squibb (BMY). Last month, the company reported a massive loss per share in the first quarter on charges related to a series of acquisitions and cut its profit